Armor Investment Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $324K | Hold |
2,119
| – | – | 0.12% | 81 |
|
|
2025
Q4 | $292K | Sell |
2,119
-200
| -9% | -$26.2K | 0.11% | 81 |
|
|
2025
Q3 | $297K | Hold |
2,319
| – | – | 0.09% | 86 |
|
|
2025
Q2 | $281K | Sell |
2,319
-559
| -19% | -$63K | 0.11% | 86 |
|
|
2025
Q1 | $321K | Hold |
2,878
| – | – | 0.13% | 80 |
|
|
2024
Q4 | $280K | Hold |
2,878
| – | – | 0.12% | 85 |
|
|
2024
Q3 | $331K | Sell |
2,878
-141
| -5% | -$16K | 0.14% | 82 |
|
|
2024
Q2 | $321K | Sell |
3,019
-529
| -15% | -$53.1K | 0.15% | 82 |
|
|
2024
Q1 | $343K | Sell |
3,548
-4,676
| -57% | -$479K | 0.17% | 82 |
|
|
2023
Q4 | $830K | Buy |
8,224
+436
| +6% | +$42.1K | 0.44% | 54 |
|
|
2023
Q3 | $793K | Buy |
7,788
+165
| +2% | +$16.7K | 0.47% | 53 |
|
|
2023
Q2 | $769K | Sell |
7,623
-668
| -8% | -$66.8K | 0.47% | 53 |
|
|
2023
Q1 | $763K | Sell |
8,291
-93
| -1% | -$8.12K | 0.44% | 56 |
|
|
2022
Q4 | $761K | Buy |
8,384
+227
| +3% | +$19.1K | 0.46% | 54 |
|
|
2022
Q3 | $620K | Sell |
8,157
-513
| -6% | -$42.5K | 0.42% | 60 |
|
|
2022
Q2 | $733K | Sell |
8,670
-281
| -3% | -$24.7K | 0.48% | 54 |
|
|
2022
Q1 | $785K | Buy |
8,951
+929
| +12% | +$80.4K | 0.44% | 57 |
|
|
2021
Q4 | $702K | Buy |
8,022
+2,653
| +49% | +$220K | 0.4% | 66 |
|
|
2021
Q3 | $439K | Sell |
5,369
-123
| -2% | -$11.1K | 0.28% | 82 |
|
|
2021
Q2 | $501K | Sell |
5,492
-42
| -0.8% | -$3.74K | 0.3% | 76 |
|
|
2021
Q1 | $473K | Buy |
5,534
+108
| +2% | +$9.69K | 0.31% | 73 |
|
|
2020
Q4 | $512K | Buy |
5,426
+1,469
| +37% | +$128K | 0.36% | 65 |
|
|
2020
Q3 | $344K | Sell |
3,957
-1,253
| -24% | -$109K | 0.29% | 73 |
|
|
2020
Q2 | $455K | Buy |
5,210
+53
| +1% | +$4.58K | 0.39% | 60 |
|
|
2020
Q1 | $425K | Sell |
5,157
-62
| -1% | -$5.53K | 0.43% | 55 |
|
|
2019
Q4 | $494K | Buy |
5,219
+55
| +1% | +$4.93K | 0.38% | 62 |
|
|
2019
Q3 | $449K | Buy |
5,164
+364
| +8% | +$32.7K | 0.37% | 65 |
|
|
2019
Q2 | $438K | Sell |
4,800
-557
| -10% | -$47.1K | 0.37% | 67 |
|
|
2019
Q1 | $461K | Sell |
5,357
-223
| -4% | -$17.9K | 0.4% | 66 |
|
|
2018
Q4 | $429K | Buy |
5,580
+446
| +9% | +$34.7K | 0.44% | 61 |
|
|
2018
Q3 | $396K | Buy |
5,134
+112
| +2% | +$8.28K | 0.35% | 69 |
|
|
2018
Q2 | $340K | Sell |
5,022
-279
| -5% | -$19.3K | 0.31% | 71 |
|
|
2018
Q1 | $384K | Buy |
5,301
+223
| +4% | +$17K | 0.35% | 69 |
|
|
2017
Q4 | $382K | Buy |
5,078
+223
| +5% | +$16.8K | 0.35% | 68 |
|
|
2017
Q3 | $373K | Buy |
4,855
+335
| +7% | +$25.3K | 0.35% | 69 |
|
|
2017
Q2 | $338K | Hold |
4,520
| – | – | 0.34% | 71 |
|
|
2017
Q1 | $301K | Buy |
4,520
+112
| +3% | +$7.46K | 0.3% | 77 |
|
|
2016
Q4 | $288K | Buy |
+4,408
| New | +$286K | 0.3% | 75 |
|
Other funds holding NVS
Armor Investment Advisors's NVS Position: Q1 2026 in Review
Armor Investment Advisors held its Novartis (NVS) position steady in Q1 2026 at 2,119 shares worth $324K. The position accounts for 0.12% of the portfolio, ranked #81.
Armor Investment Advisors first reported a position in NVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $830K in Q4 2023. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Armor Investment Advisors held 2,119 shares of Novartis worth $324K as of Q1 2026.
- Armor Investment Advisors left its Novartis share count unchanged in Q1 2026.
- Novartis made up 0.12% of Armor Investment Advisors's portfolio in Q1 2026, its #81 holding.
- Armor Investment Advisors first reported a position in Novartis in Q4 2016 and has held it in 38 quarters since.
- Armor Investment Advisors's Novartis position peaked at $830K in Q4 2023.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Armor Investment Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.